Novo Nordisk AS (NVO)

Industry Drug Manufacturers - General
This stock can be held in an Investment ISA and an Investment Account
Sell

$105.09

Buy

$105.25

arrow-up$2.43 (+2.37%)

Prices updated at 22 Nov 2024, 00:00
| Prices minimum 15 mins delay
|
Prices in USD
Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company’s business segments include, diabetes and obesity care, and biopharmaceuticals.
S&P 500
arrow-up0.35%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
$106.24 - $103.86
$148.15 - $94.73
1.29
450,105.94m
35.31
-
6,143,345
27.60
4,631,853.47
0.48
4,510.00m
US6701002056
21.20
-
Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2024 Morningstar. All rights reserved.